|
TVIS44037874
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr2 |
5199407 |
5199407 |
p25.2 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037875
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr2 |
51242169 |
51242169 |
p16.3 |
NRXN1-DT |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037876
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr2 |
50977794 |
50977794 |
p16.3 |
NRXN1 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037877
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr2 |
50977785 |
50977785 |
p16.3 |
NRXN1 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037878
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr2 |
50977763 |
50977763 |
p16.3 |
NRXN1 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037879
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr2 |
46408567 |
46408567 |
p21 |
LINC01820 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037880
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr2 |
46408548 |
46408548 |
p21 |
LINC01820 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037881
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr2 |
46408543 |
46408543 |
p21 |
LINC01820 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037882
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr2 |
46408531 |
46408531 |
p21 |
LINC01820 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037883
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr2 |
41495038 |
41495038 |
p22.1 |
ENSG00000301031 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |